Acer, Relief win FDA approval for rare metabolic disease after clearing inspection hurdles
Acer Therapeutics and its Swiss partner Relief Therapeutics celebrated an FDA approval on Tuesday for Olpruva, an oral drug for urea cycle disorders (UCDs).
The news comes roughly six months after regulators rejected Olpruva, also known as ACER-001, because its contract packaging manufacturer wasn
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!